Bio Bytes 21: Antiviral Drug Development with Dr. Alex Chavez

Columbia University Bio Bytes
20/02/2021 47 min

Listen "Bio Bytes 21: Antiviral Drug Development with Dr. Alex Chavez"

Descargar episodio Ver en sitio original

Episode Synopsis

In which Aaron speaks with Alex Chavez, MD-PhD about antiviral drug development. They discuss chemical strategies for protease inhibitor development and the details and rationale of a novel assay that allows for early validation of candidate drugs. Additionally Alex discusses newer collaborations he is engaged in to build cellular resistance to damaging radiation. 

More episodes of the podcast Columbia University Bio Bytes

Bio Bytes 44: AI to Bridge Biology and Medicine with Dr. Nima Aghaeepour 08/09/2025
Bio Bytes 43 [BenchtoBedside Series]: Pediatric Cardiology and AI with Dr. Son Duong 02/09/2025
Bio BITES 42: Bites, Blood Meals, and Behavioral Switches: Decoding Mosquito Behavior with Dr. Duvall 01/06/2025
Bio Bytes 41: From Bedside to Breakthrough: Dr. Rosenblatt on Innovation and Impact in Anesthesiology 23/05/2025
Bio Bytes 40: Engineering Novel Immune Circuits with Dr. Livnat Jerby 28/04/2025
Bio Bytes 39 [BenchtoBedside Series]: Biomedical Informatics in Neurocritical Care with Dr. Soojin Park 28/01/2025
Bio Bytes 38 [BenchtoBedside Series]: Biomedical Informatics with Dr. George Hripcsak 06/01/2025
Bio Bytes 37: Academia, Scientific Publishing, and Translational Research in Targeted Protein Degradation with Michele Pagano 05/11/2024
Bio Bytes 36 [BenchtoBedside Series]: Nuclear Medicine and Molecular Imaging with Dr. Akiva Mintz 25/09/2024
Bio Bytes 35: Olfactory Transduction with Stuart Firestein and More on Public Engagement with Science 24/10/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA